Anonymous
Guest
Anonymous
Guest
Agree on most posts, however, rumor is we have been in the works to buy or co-market something. Will this be sooner now that the cluster-f___ known as Novartis senior leadership has done it again and totally screwed up a decent product (remember zelnorm?) Many heads in East Hanover should roll right out onto Rt 10 after this is over because they will have caused the demise of the company and directly caused the loss of hundreds of jobs. Our very credibility is shot. How do we now promote what's left (of, course, before the patents are challenged) and get any business. This isn't like when we lost Lotrel because there were plenty of products to promote. Now we have nothing. End of story.
How long will it be before JJ, BG AW and others resign? Let's wait and see.
This post is absolutely correct. Credibility is shot and that is a death sentence.
Even if by some miracle they have a new drug to promote, which they don't, what doctor is going to trust the message after the Tekturna fiasco? It's not that the doctors will suddenly decide they don't like the rep, it will be I don't like Novartis. Especially when doctors will now have to pull charts, call patients and take them off this drug before they have that first mild to moderate stroke.
Not to mention managed health care contracts. I can just see the pharmacy directors embracing another "new" world class Novartis agent especially while all those malpractice ads are running on the airways putting a few unemployed lawyers back to work.
I think the company released this purposely now before Christmas since Wall Street is shut down until Jan 3rd therefore the stock won't take as big of a hit and the news cycle will have passed over moving on to other stories. Gotta give them credit for timing the press release correctly it's a shame they cannot seem to manage the portfolio this well.